ON THE PATH
TOWARD THE POSSIBLE

At Flare Therapeutics, we have built a novel pipeline of programs from select transcription factors with robust genetic and biologic validation, initially focused on precision oncology with lead programs in prostate cancer and advanced urothelial cancer.